Sana Biotechnology, Inc.

Creating and delivering engineered cells as medicine for patients

Sana Biotechnology, Inc. founded in 2018, is focused on creating and delivering engineered cells as medicine for patients. Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases. The company's scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and will change how we approach treating disease.